Workflow
中宠股份(002891):自主品牌持续提升,Q3扣非后净利润同比增18.9%业绩概要

Investment Rating - The report assigns a "Buy" rating for the company, indicating a potential upside in the stock price [3][8]. Core Insights - The company has shown robust revenue growth, with a 21% year-on-year increase in revenue for the first three quarters of 2025, reaching RMB 3.86 billion. The net profit attributable to shareholders was RMB 330 million, reflecting an 18.2% increase year-on-year [8]. - The third quarter saw a revenue of RMB 1.43 billion, a 15.9% increase year-on-year, although the net profit decreased by 6.6% to RMB 130 million due to prior investment income in Q3 2024 [8][11]. - The company is expected to maintain strong growth in both domestic and international markets, with a focus on enhancing brand influence and expanding product offerings [11]. Financial Performance Summary - For the fiscal year ending December 31, 2025, the company is projected to achieve a net profit of RMB 479 million, a 21.67% increase from the previous year. The earnings per share (EPS) is expected to be RMB 1.57 [10]. - The price-to-earnings (P/E) ratio is projected to decrease from 40 in 2024 to 34 in 2025, indicating a more attractive valuation as earnings grow [10]. - The company’s revenue is forecasted to grow from RMB 5.62 billion in 2025 to RMB 6.92 billion in 2026, reflecting a strong upward trend in sales [15]. Market Position and Shareholder Information - The company operates primarily in the pet food sector, with 70.16% of its revenue coming from pet snacks, 24.78% from pet food, and 5.06% from pet supplies [3]. - Major shareholders include Yantai Zhongxing Biological Technology Co., Ltd., holding 24.02% of the shares [2]. - Institutional investors hold 6.1% of the circulating A-shares, while general corporations hold 62.6% [4].